Bourgonje, Arno R.
Wichers, Sietse J.
Hu, Shixian
van Dullemen, Hendrik M.
Visschedijk, Marijn C.
Faber, Klaas Nico
Festen, Eleonora A. M.
Dijkstra, Gerard
Samsom, Janneke N.
Weersma, Rinse K.
Spekhorst, Lieke M.
Funding for this research was provided by:
JSM (17-57)
TIMID (LSHM18057-SGF, LSHM18057-SGF)
Article History
Received: 9 February 2022
Accepted: 26 July 2022
First Online: 26 August 2022
Competing interests
: G.D. received research grants from Royal DSM and speaker’s fees from Janssen Pharmaceuticals, Takeda, Pfizer and Abbvie. R.K.W. acted as consultant for Takeda, received unrestricted research grants from Takeda, Johnson & Johnson, Tramedico and Ferring, and received speaker’s fees from MSD, Abbvie and Janssen Pharmaceuticals. A.R.B., S.J.W., S.H., H.M.v.D., M.C.V., K.N.F., E.A.M.F., J.N.S. and L.M.S. declare no potential conflict of interest.